LeMaitre Vascular Q2 Net Sales +9.6% to $70.4M; EPS $0.74
LeMaitre Vascular reported strong financial results for the second quarter and first half of 2026. Net sales for Q2 increased 9.6% to $70.4 million, while net income surged 23.7% to $17.1 million, leading to a diluted EPS of $0.74. For the first six months, net sales grew 10.3% to $136.9 million and net income climbed 32.0% to $32.7 million. The company also declared a quarterly cash dividend of $0.25 per share, a 25% increase from the prior year, and adjusted its convertible senior notes conversion rate accordingly.
Key Highlights
- Q2 2026 Net Sales increased 9.6% to $70.4 million from $64.2 million in Q2 2025.
- Q2 2026 Net Income rose 23.7% to $17.1 million from $13.8 million in Q2 2025.
- Q2 2026 Diluted EPS was $0.74, a 23.3% increase from $0.60 in Q2 2025.
- H1 2026 Net Sales grew 10.3% to $136.9 million from $124.1 million in H1 2025.
- H1 2026 Net Income increased 32.0% to $32.7 million from $24.8 million in H1 2025.
- Quarterly cash dividend declared was $0.25 per share, up from $0.20 in Q2 2025.
- Net cash provided by operating activities for H1 2026 was $31.1 million, up 5.9% YoY.
- Convertible senior notes conversion rate adjusted to 8.3820 shares due to increased dividend.
Price Impact
More from LMAT
LeMaitre Vascular Announces Management Participation in Investor Conferences
LeMaitre Vascular Q3 Sales Up, EPS Mixed; Declares $0.25 Dividend
LeMaitre Vascular Q3 Sales Up 11% to $68M; Acquires B. Braun Assets